Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 238
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible...
Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum...
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst...
Wesana Health Announces Closing of PsyTech Acquisition
Levitee Labs Commences Trading in U.S. Under Ticker LVTTF
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development
Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering...
Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1
No, VR Will Not Give You A Psychedelic Trip
PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year...
Load more